Sarcomatrix Therapeutics Named Seed-Stage Finalist at BIO International Convention's Start-Up Stadium 2026
Clinical-stage biotechnology company advancing therapies for neuromuscular diseases selected to present before leading global investors and strategic partners RENO, NV, UNITED STATES, June 16, 2026 /EINPresswire.com/ -- Sarcomatrix Therapeutics …